Dutasteride vs TB-4 Topical (Hair)
A side-by-side research comparison of Dutasteride and TB-4 Topical (Hair) across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Dutasteride | TB-4 Topical (Hair) |
|---|---|---|
| Full name | Dutasteride (Avodart) | Thymosin Beta-4 Topical (Hair Growth) |
| Category | Hair Growth | Hair Growth |
| Status | FDA Approved (BPH) / Off-label hair loss | Research compound |
| Mechanism | Inhibits both type I and type II 5-alpha reductase isoenzymes, reducing serum DHT by ~90% and scalp DHT by ~50%. Prevents miniaturization of androgen-sensitive hair follicles in the vertex and frontal scalp. | Promotes migration and differentiation of hair follicle stem cells via actin sequestration and cell motility enhancement. Activates quiescent stem cells in the bulge niche. Stimulates new blood vessel formation around follicles for nutrient delivery. |
| Molecular weight | 528.53 Da | 4921 Da |
| Half-life | ~5 weeks (extremely long) | ~6 hours (systemic); local depot effect (topical) |
| Bioavailability | ~60% oral | Topical: penetrates to bulge region with microneedling |
| Typical dose | 0.5 mg | 50-200 mcg per scalp application or 0.1% solution |
| Frequency | Daily | 3x weekly |
| Route | Oral capsule | Topical serum or mesotherapy (intradermal injection) |
Dutasteride reported benefits
- Superior DHT suppression vs finasteride
- Hair regrowth and thickening
- Reduced hair miniaturization
- Prostate volume reduction
- Effective for diffuse thinning
TB-4 Topical (Hair) reported benefits
- Hair follicle stem cell activation
- Dormant follicle reactivation
- Scalp angiogenesis
- Anti-inflammatory for scalp
- Synergistic with microneedling
- Novel mechanism (stem cell migration)
Related comparisons
Research and educational reference only. Not medical advice.